« Previous
Next »
Titles
- From ballot initiative to waivers: what is the status of Medicaid expansion in Utah?2
- Interpretation of and compliance policy for certain label requirement: applicability of certain Federal Food, Drug, and Cosmetic Act requirements to vape shops2
- 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff1
- Access to health insurance1
- Administrative rulemaking1
- Benefits and services1
- Business of health insurance1
- Californians maintain health insurance coverage despite national trends1
- Changes in health coverage by race and ethnicity since implementation of the ACA: 2013-20171
- Changes to existing medical software policies resulting from section 3060 of the 21st Century Cures Act: guidance for industry and Food and Drug Administration staff1
- Citizen petitions and petitions for stay of action subject to section 505(q) of the Federal Food, Drug, and Cosmetic Act1
- Community health centers and the President’s HIV Initiative: issues and challenges facing health centers in high-burden states and communities1
- Comparing health insurance reform options: from "building on the ACA" to single payer1
- Compliance policy for certain compounding of oral oxitriptan (5-HTP) drug products for patients with tetrahydrobiopterin (BH4) deficiency: immediately in effect guidance for industry1
- Could a public health insurance option lead to more competitive markets?1
- Delivery reform1
- Determining whether to submit an ANDA or a 505(b)(2) application1
- Did the Affordable Care Act reduce racial and ethnic disparities in health insurance coverage?1
- Easing the stigma of public coverage: workers with health coverage at their jobs get significant government aid too1
- Effects of the Patient Protection and Affordable Care Act on coverage and access to care in metropolitan vs. non-metropolitan areas through 20161